ZeaChem Breaks Ground for New Biorefinery in Oregon

ZeaChem Inc., a developer of biorefineries for the conversion of renewable biomass into sustainable fuels and chemicals, held a groundbreaking ceremony today for its 250,000 gallon-per-year biorefinery in Boardman, Oregon. The company will build commercial scale biorefineries upon successful operations at the Boardman facility.

The plant will initially use ZeaChem’s core technology, which has been validated by a number of third party vendors, to produce ethyl acetate, a salable chemical intermediate and precursor to cellulosic ethanol. ZeaChem’s fermentation technology has been built and tested at Hazen Research facility in Golden, Colorado and numerous industry vendors have validated the additional process units including acetic acid concentration and ethyl acetate production. Using an American Recovery and Reinvestment Act (ARRA) grant from the U.S. Department of Energy (DOE), the company will add the cellulosic ethanol production capability to come online in 2011.

Oregon Governor Ted Kulongoski, ZeaChem President & CEO Jim Imbler and U.S. Senator Ron Wyden break ground on ZeaChem's biorefinery in Boardman, OR.

“ZeaChem’s biorefinery in Boardman is another example of our effort to attract green companies and advance the development of cellulosic ethanol as a viable renewable energy resource,” said Oregon Governor Ted Kulongoski. “Companies like ZeaChem will help drive Oregon’s economy in the 21st century as well as move us toward greater energy security and independence.”

“Projects like the ZeaChem biorefinery in Boardman will help create jobs in a part of Oregon that badly needs them, while at the same time moving our nation a little closer towards less reliance on fossil fuel, both foreign and domestic,” said U.S. Senator Ron Wyden. “What America needs is more renewable energy options to replace the fossil fuels that have proven to be so destructive to the health of our environment. I look forward to biorefineries like ZeaChem’s taking their place in our nation’s menu of energy solutions.”

The Oregon Employment Department calculates that the construction and operation of ZeaChem’s Boardman biorefinery will create 292 direct and indirect jobs in Oregon, 167 of which will be located in Morrow County, where Boardman is located.

“Breaking ground on ZeaChem’s biorefinery in Boardman is a significant milestone,” said Jim Imbler, president and chief executive officer of ZeaChem. “ZeaChem is greatly appreciative of the support from the local, state and federal governments, our investors, project partners and others who have made this possible. As a leader in this industry, ZeaChem is committed to producing economical and sustainable advanced biofuels and bio-based chemicals, creating jobs, and being a good neighbor in the community.”

ZeaChem has a contract with GreenWood Resources (GWR), a Portland-based timberland investment manager, to obtain sustainable hybrid poplar tree feedstock from the nearby farms held under GreenWood Tree Farm Fund, LP. Because the technology is feedstock agnostic, ZeaChem will also process trials of herbaceous crops, agricultural residuals and other renewable biomass resources. ZeaChem’s “grow where you go” strategy locates production facilities with dedicated energy crops to minimize the transportation and logistics costs of cellulosic biofuel and bio-based chemical production. Contracting with GWR eliminates much of the feedstock price risk and ensures continuity of supply. ZeaChem will supplement its dedicated energy crop supply with additional local residuals.

With groundbreaking on the core process in Boardman underway and the future addition of the DOE grant-funded cellulosic ethanol capacity, ZeaChem is on schedule to begin production of cellulosic ethanol in 2011.

Source: http://www.zeachem.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.